|
시장보고서
상품코드
1624189
오가노이드 시장 규모 및 예측 : 세계 및 지역 점유율, 동향, 성장 기회 분석 리포트 - 유형별, 용도별, 공급원별, 제공별, 방법별, 지역별Organoids Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, Source, Offering, Method, and Geography |
||||||
The Insight Partners의 새로운 조사 리포트 '오가노이드 시장 예측(-2031년) : 세계 분석 - 유형, 용도, 공급원, 지역별'에 따르면 오가노이드 시장은 2023년 30억 3,000만 달러에서 성장하며, 2031년에는 150억 1,000만 달러에 달할 것으로 예측되며, 2023-2031년에 22.1%의 CAGR을 기록할 것으로 예측됩니다. 오가노이드 시장의 성장 요인으로는 신규 약물 스크리닝 서비스에 대한 수요 증가, 맞춤형 약물의 인기 상승 등을 꼽을 수 있습니다. 그러나 숙련된 전문가 부족과 엄격한 안전 규제가 시장 성장의 걸림돌로 작용하고 있습니다.
오가노이드는 간단한 조직공학 세포 기반 in vitro 모델로서, 해당 in vivo 조직의 복잡한 구조와 기능의 많은 측면을 재현합니다. 또한 진단, 질병 모델, 신약 개발, 맞춤형 의료에도 활용할 수 있습니다.
북미가 오가노이드 시장을 지배하고 있습니다. 2023년 2월, Molecular Devices, LLC.와 HUB Organoids(HUB)는 전임상부터 임상까지의 약물 감소를 단계적으로 감소시키는 차세대 3D 생물학 기술 개발을 위한 전략적 제휴를 발표했습니다. 발표하였습니다. 또한 연구개발 활동 증가, 조직공학 및 장기 이식에 대한 수요 증가, 오가노이드의 높은 도입률이 국내 오가노이드 서비스 시장을 주도하고 있습니다. 오가노이드는 생물 의학 연구와 관련된 몇 가지 한계를 극복할 수 있는 잠재력을 가지고 있으며, 인간 연구개발의 메커니즘적 인사이트을 연구자들이 이용할 수 있도록 하고, 인간 질환의 정확한 모델을 만들고, 재생 의료용 환자 맞춤형 조직 소스를 생성하는 데 높은 관심을 받고 있습니다. 관심이 집중되고 있습니다. 아시아태평양은 2023-2031년 가장 높은 CAGR을 나타낼 것으로 예상됩니다.
신흥 국가의 주요 발전은 향후 시장 개척의 기회를 가져다 줄 것입니다.
헬스케어의 발전으로 인해 전 세계에서 오가노이드에 대한 수요가 증가하고 있습니다. 이러한 수요 증가는 세계 차원의 신제품 개발, 인수, 제휴, 제품 출시 및 승인에 기여하고 있습니다. 주요 시장 기업은 효율적인 서비스 및 제품 혁신과 개발을 보장하기 위한 활동에 참여하고 있습니다. 최근 몇 가지 동향은 다음과 같다:
2024년 6월, Molecular Devices, LLC.는 영국 카디프에 전용 시설을 정식으로 오픈했습니다. 수백만 파운드가 투자된 이 시설은 분자디바이스의 독자적인 바이오프로세스 워크플로우와 혁신적인 바이오리액터 기술을 위해 설계되어 PDO를 대규모로 품질관리된 방식으로 생산할 수 있게 되었으며, 3D 대응이 가능한 재현성 높은 PDO를 맞춤형 서비스로 대량으로 제공하고 분석에 적합한 형태로 분석에 적합한 형태로 동결보존할 수 있습니다. 연구자들은 필요에 따라 이들 제품을 해동, 플레이트화하여 사용할 수 있습니다.
2024년 5월, 생명공학 기업 InSphero는 프랑크푸르트에 위치한 Genome Biologics와 파트너십 계약을 체결했습니다. 이번 파트너십을 통해 InSphero는 Genome Biologics의 3D 심장 오가노이드 플랫폼을 상용화할 수 있는 독점적 세계 독점권을 획득하게 됩니다. 이 플랫폼은 새로운 치료법을 개발할 수 있는 정확하고 확장 가능한 질병 특이적 오가노이드 모델을 제공하여 심장병 연구의 최전선에 서게 될 것입니다.
2023년 7월, 분자디바이스는 하이스루풋 용도를 위한 독자적인 바이오프로세스 기술을 이용한 맞춤형 유기체 라인 확장 서비스를 시작했습니다.
2023년 2월, Molecular Devices, LLC.와 HUB Organoids(HUB)는 전략적 제휴를 발표하고 전임상에서 임상으로의 약물 감소를 단계적으로 감소시키는 차세대 3D 생물학 기술의 지속적인 개발에 기여합니다.
2022년 12월, Molecular Devices, LLC.는 Cellesce Ltd.를 인수했습니다. 이번 인수는 위탁 개발 및 생산 서비스를 통해 약물 스크리닝을 포함한 다양한 목적의 대규모 PDO 생산에 초점을 맞추었습니다.
2021년 8월, STEMCELL Technologies와 Hubrecht Organoid Technology(HUB)는 계약을 체결했습니다. 이 계약의 일환으로 STEMCELL의 계약 분석 서비스 부문은 전임상 독성학 스크리닝 및 비항암제 개발 서비스를 위해 폐, 장, 간 등 조직 유래 오가노이드를 HUB에 공급하기 시작했습니다. 이러한 서비스는 연구자 및 의약품 개발 조직이 전임상시험 프로그램에 오가노이드를 통합하여 새로운 치료법을 신속하고 경제적으로 출시할 수 있도록 돕습니다.
이러한 신흥 국가 시장의 주요 발전, 시장 진입, 시장 관계자들 간의 전략적 제휴는 오가노이드 시장 개발에 충분한 기회를 창출할 것입니다.
용도별 인사이트
용도별로는 발생생물학, 감염 병리학, 재생의료, 약물 독성 및 유효성 시험, 신약개발 및 맞춤의료, 기타로 구분됩니다. 발생생물학 질환 분야는 2023년 시장에서 가장 큰 점유율을 차지할 것으로 예상되며, 2023-2031년 가장 높은 CAGR을 나타낼 것으로 예측됩니다.
공급처 기반 인사이트
장기 시장은 공급원에 따라 유도만능줄기세포와 장기특이적 성체줄기세포로 구분되며, 2023년 시장에서는 유도만능줄기세포 부문이 큰 비중을 차지할 것으로 예상됩니다. 다능성 줄기세포 부문은 예측 기간 중 높은 CAGR을 나타낼 것으로 예상됩니다.
오가노이드 시장 경쟁 구도 및 주요 발전
STEMCELL Technologies Inc, Molecular Devices, LLC, InSphero, Definigen, Organoid Therapeutics, Thermo Fisher Scientific Inc, Corning Inc, Merck KGaA, HUB Organoids B.V.(Hubrecht Organoid Technology) 등이 오가노이드 시장에서 사업을 도입하는 주요 기업입니다.
미국 식품의약국(FDA), 질병통제예방센터(CDC), 세계질병부담조사(Global Burden of Disease Study) 등은 유기체 시장 보고서 작성시 참고한 1차 및 2차 정보입니다.
목차
제1장 서론
제2장 개요
- 중요한 인사이트
제3장 조사 방법
- 2차 조사
- 1차 조사
- 가설 책정
- 거시경제 요인 분석
- 기초 수치의 개발
- 데이터 삼각측량
- 국가 레벨 데이터
제4장 오가노이드 시장 구도
- PEST 분석
제5장 오가노이드 시장 역학
- 오가노이드 시장 - 주요 시장 역학
- 시장 성장 촉진요인
- 종양 모델링과 바이오뱅크의 수요 증가
- 맞춤형 의약품의 채택 급증
- 시장 성장 억제요인
- 숙련 전문가의 부족
- 시장 기회
- Drug Discovery 활동에 대한 초점
- 향후 동향
- 오가노이드와 Organ-on-a-Chip의 조합
- 촉진요인과 억제요인의 영향
제6장 오가노이드 시장 - 세계 시장 분석
- 오가노이드 시장 매출, 2021-2031년
- 오가노이드 시장 예측 분석
제7장 오가노이드 시장 분석 - 유형별
- 장
- 간
- 위
- 췌장
- 폐
- 뇌
- 신장
- 기타
제8장 오가노이드 시장 분석 - 용도별
- 발생생물학 질환
- 감염증 병리학
- 재생의료
- 약물 독성 및 유효성 시험
- Drug Discovery와 맞춤형 의료
- 기타
제9장 오가노이드 시장 분석 : 공급원별
- 다능성 줄기세포
- 장기 특이적 성체 줄기세포 70
제10장 오가노이드 시장 분석 - 제공별
- 기구
- 소모품
- 서비스
제11장 오가노이드 시장 분석 - 방법별
- 마이크로패턴 플레이트
- 초저 어태치먼트 플레이트
- 행잉 드롭
- 미소 액적 또는 에멀전
- 기타
제12장 오가노이드 시장 분석 - 지역별
- 개요
- 북미
- 북미
- 미국
- 캐나다
- 멕시코
- 북미
- 유럽
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 기타 유럽
- 유럽
- 아시아태평양
- 아시아태평양
- 일본
- 중국
- 인도
- 한국
- 호주
- 싱가포르
- 태국
- 말레이시아
- 베트남
- 인도네시아
- 필리핀
- 아시아태평양의 기타 국가
- 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카
- 사우디아라비아
- 남아프리카공화국
- 아랍에미리트
- 기타 중동 및 아프리카
- 중동 및 아프리카
- 중남미
- 중남미
- 브라질
- 아르헨티나
- 기타 중남미
- 중남미
제13장 업계 상황
- 오가노이드 시장에서의 성장 전략
- 유기적 성장 전략
- 개요
- 무기적 성장 전략
- 개요
제14장 기업 개요
- STEMCELL Technologies Inc.
- Molecular Devices, LLC.
- Hubrecht Organoid Technology.
- Definigen.
- Organoid Therapeutics.
- Thermo Fisher Scientific Inc.
- Corning Inc.
- Merck KGaA.
- InSphero.
- ACRO Biosystems.
- Bio-Techne Corp.
- SUN bioscience SA.
- ORGANOID SCIENCES Co., Ltd.
- Crown Bioscience Inc.
- Sartorius AG.
- 3D Biotek LLC.
- Prellis Biologics Inc.
- 3Dnamics Inc.
- Cellesce Ltd.
제15장 부록
KSA 25.02.05According to our new research study on "Organoids Market Forecast to 2031 -Global Analysis - by Type, Application, Source, and Geography," the market is anticipated to grow from US$ 3.03 billion in 2023 and is projected to reach US$ 15.01 billion by 2031; it is expected to register a CAGR of 22.1% during 2023-2031. Factors contributing to the organoids market growth include the rising demand for novel drug screening services, and an upsurge in the popularity of customized medications. However, the dearth of skilled professionals and stringent safety regulations hamper the market growth.
Organoids are simple tissue-engineered cell-based in vitro models that recapitulate many aspects of the complex structure and function of the corresponding in vivo tissue. They can be dissected and interrogated for fundamental mechanistic studies on development, regeneration and repair in human tissues, and can also be used in diagnostics, disease modelling, drug discovery and personalized medicine.
North America dominates the organoids market. Market players in the US are focusing on organic growth strategies to strengthen their foothold. In February 2023, Molecular Devices, LLC. and HUB Organoids (HUB) announced a strategic collaboration to continue the development of next-generation 3D biology technologies that drive step-change reduction in preclinical to clinical drug attrition. Further, increasing research and development activities, rising demand for tissue engineering and organ transplantation, and a high rate of organoid adoption are driving the organoid services market in the country. Organoids have the potential to overcome several previous limitations associated with biomedical research studies, with a high focus on making mechanistic insights on human development available for researchers, producing accurate models of human disease, and generating patient-matched tissue sources for regenerative medicine. Asia Pacific is anticipated to record the highest CAGR during 2023-2031.
Increasing Key Developments to Provide Market Opportunities in Future
The progress of the healthcare sector has led to a rise in the demand for organoids across the world. This increased demand contributes to new product developments, acquisitions, partnerships, product launches, and approvals on a global level. Major market players are involved in activities to ensure the innovation and development of efficient services and products. A few of the recent key developments are listed below:
In June 2024, Molecular Devices, LLC. formally opened its purpose-built facility in Cardiff, UK. The multimillion-pound facility was designed to accommodate the exclusive bioprocess workflow and innovative bioreactor technology of the business, allowing for the large-scale, quality-controlled production of PDOs. Substantial amounts of repeatable PDOs that are 3D-ready are available as a custom service and are cryopreserved in a manner that is ready for analysis. Researchers can defrost, plate, and use these products as needed.
In May 2024, InSphero, a biotech company, signed a partnership agreement with Genome Biologics, Frankfurt. In this partnership, InSphero will receive the exclusive global rights to commercialize Genome Biologics' 3D Cardiac Organoid Platform. The platform provides accurate, scalable, and disease-specific organoid models for creating novel treatments, placing it at the forefront of heart disease research.
In July 2023, Molecular Devices launched a custom organoid line expansion service with unique bioprocess technology for high-throughput applications.
In February 2023, Molecular Devices, LLC., and HUB Organoids (HUB) announced a strategic collaboration to contribute to the continued development of next-generation 3D biology technologies that enable step-change reduction in preclinical to clinical drug attrition.
In December 2022, Molecular Devices, LLC. acquired Cellesce Ltd. This acquisition focuses on producing large-scale PDOs for various purposes, including drug screening, through contract development and production services.
In August 2021, STEMCELL Technologies and Hubrecht Organoid Technology (HUB) signed an agreement. As a part of this agreement, STEMCELL's Contract Assay Services division began providing its tissue-derived organoids, such as lung, intestinal, and liver organoids, for pre-clinical toxicology screening and non-cancer drug development services to HUB. These services would facilitate the integration of organoids into preclinical testing programs by researchers and drug development organizations to aid in the faster and more economical launch of new therapies.
Such key developments, launches, and strategic collaborations among market players create ample opportunities for the organoid market growth..
Application -Based Insights
By application, the market is segmented into developmental biology, infectious disease pathology, regenerative medicine, drug toxicity & efficacy testing, drug discovery & personalized medicine, and others. The developmental biology disease segment held the largest share of the market in 2023; it is further anticipated to register the highest CAGR during 2023-2031.
Source -Based Insights
Based on source, the organoids market is divided into pluripotent stem cells and organ-specific adult stem cells. The pluripotent stem cells segment held a larger share of the market in 2023. The pluripotent stem cells segment is anticipated to register a higher CAGR during the forecast period.
Organoids Market: Competitive Landscape and Key Developments
STEMCELL Technologies Inc, Molecular Devices, LLC., InSphero, Definigen, Organoid Therapeutics, Thermo Fisher Scientific Inc, Corning Inc, Merck KGaA, HUB Organoids B.V. (Hubrecht Organoid Technology) are among the key companies operating in the organoids market.
The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Global Burden of Disease Study are among the primary and secondary sources referred to while preparing the organoids market report.
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance.
- 1.2 Market Segmentation.
2. Executive Summary
- 2.1 Key Insights.
3. Research Methodology
- 3.1 Secondary Research.
- 3.2 Primary Research.
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Organoids Market Landscape
- 4.1 PEST Analysis.
5. Organoids Market - Key Market Dynamics
- 5.1 Organoids Market - Key Market Dynamics.
- 5.2 Market Drivers.
- 5.2.1 Increasing Demand for Tumor Modeling and Biobanking.
- 5.2.2 Surging Adoption of Personalized Drugs.
- 5.3 Market Restraints.
- 5.3.1 Dearth of Skilled Professionals.
- 5.4 Market Opportunities.
- 5.4.1 Focus on Drug Discovery Activities.
- 5.5 Future Trends.
- 5.5.1 Combination of Organoids and Organ-on-a-Chip.
- 5.6 Impact of Drivers and Restraints:
6. Organoids Market - Global Market Analysis
- 6.1 Organoids Market Revenue (US$ Million), 2021-2031.
- 6.2 Organoids Market Forecast Analysis.
7. Organoids Market Analysis - by Type
- 7.1 Intestine.
- 7.1.1 Overview.
- 7.1.2 Intestine: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 7.2 Liver
- 7.2.1 Overview.
- 7.2.2 Liver: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 7.3 Stomach.
- 7.3.1 Overview.
- 7.3.2 Stomach: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 7.4 Pancreas.
- 7.4.1 Overview.
- 7.4.2 Pancreas: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 7.5 Lung.
- 7.5.1 Overview.
- 7.5.2 Lung: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 7.6 Brain.
- 7.6.1 Overview.
- 7.6.2 Brain: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 7.7 Kidney.
- 7.7.1 Overview.
- 7.7.2 Kidney: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 7.8 Others.
- 7.8.1 Overview.
- 7.8.2 Others: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
8. Organoids Market Analysis - by Application
- 8.1 Developmental Biology Disease.
- 8.1.1 Overview.
- 8.1.2 Developmental Biology Disease: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 8.2 Pathology of Infectious Disease.
- 8.2.1 Overview.
- 8.2.2 Pathology of Infectious Disease: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 8.3 Regenerative Medicine.
- 8.3.1 Overview.
- 8.3.2 Regenerative Medicine: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 8.4 Drug Toxicity and Efficacy Testing.
- 8.4.1 Overview
- 8.4.2 Drug Toxicity and Efficacy Testing: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 8.5 Drug Discovery and Personalized Medicine.
- 8.5.1 Overview.
- 8.5.2 Drug Discovery and Personalized Medicine: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 8.6 Others.
- 8.6.1 Overview.
- 8.6.2 Others: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
9. Organoids Market Analysis - by Source
- 9.1 Pluripotent Stem Cells
- 9.1.1 Overview.
- 9.1.2 Pluripotent Stem Cells: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 9.2 Organ-Specific Adult Stem Cell 70
- 9.2.1 Overview.
- 9.2.2 Organ-Specific Adult Stem Cell: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
10. Organoids Market Analysis - by Offering
- 10.1 Instruments.
- 10.1.1 Overview.
- 10.1.2 Instruments: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 10.2 Consumables.
- 10.2.1 Overview.
- 10.2.2 Consumables: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 10.3 Services.
- 10.3.1 Overview.
- 10.3.2 Services: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
11. Organoids Market Analysis - by Method
- 11.1 Micropatterned Plates.
- 11.1.1 Overview.
- 11.1.2 Micropatterned Plates: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 11.2 Ultralow Attachment Plates.
- 11.2.1 Overview.
- 11.2.2 Ultralow Attachment Plates: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 11.3 Hanging Drop.
- 11.3.1 Overview.
- 11.3.2 Hanging Drop: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 11.4 Microdroplet or Emulsion.
- 11.4.1 Overview.
- 11.4.2 Microdroplet or Emulsion: Organoids Market - Revenue and Forecast to 2031 (US$ Million) 79
- 11.5 Others.
- 11.5.1 Overview.
- 11.5.2 Others: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
12. Organoids Market - Geographical Analysis
- 12.1 Overview.
- 12.2 North America.
- 12.2.1 North America Organoids Market Overview.
- 12.2.2 North America: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.2.3 North America: Organoids Market Breakdown, by Type.
- 12.2.3.1 North America: Organoids Market - Revenue and Forecast Analysis - by Type.
- 12.2.4 North America: Organoids Market Breakdown, by Application.
- 12.2.4.1 North America: Organoids Market - Revenue and Forecast Analysis - by Application.
- 12.2.5 North America: Organoids Market Breakdown, by Source.
- 12.2.5.1 North America: Organoids Market - Revenue and Forecast Analysis - by Source.
- 12.2.6 North America: Organoids Market Breakdown, by Offering.
- 12.2.6.1 North America: Organoids Market - Revenue and Forecast Analysis - by Offering.
- 12.2.7 North America: Organoids Market Breakdown, by Instruments.
- 12.2.7.1 North America: Organoids Market - Revenue and Forecast Analysis - by Instruments.
- 12.2.8 North America: Organoids Market Breakdown, by Consumables.
- 12.2.8.1 North America: Organoids Market - Revenue and Forecast Analysis - by Consumables.
- 12.2.9 North America: Organoids Market Breakdown, by Method.
- 12.2.9.1 North America: Organoids Market - Revenue and Forecast Analysis - by Method.
- 12.2.10 North America: Organoids Market - Revenue and Forecast Analysis - by Country.
- 12.2.10.1 North America: Organoids Market - Revenue and Forecast Analysis - by Country.
- 12.2.10.2 United States: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.2.10.2.1 United States: Organoids Market Breakdown, by Type.
- 12.2.10.2.2 United States: Organoids Market Breakdown, by Application.
- 12.2.10.2.3 United States: Organoids Market Breakdown, by Source.
- 12.2.10.2.4 United States: Organoids Market Breakdown, by Offering.
- 12.2.10.2.5 United States: Organoids Market Breakdown, by Instruments.
- 12.2.10.2.6 United States: Organoids Market Breakdown, by Consumables.
- 12.2.10.2.7 United States: Organoids Market Breakdown, by Method.
- 12.2.10.3 Canada: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.2.10.3.1 Canada: Organoids Market Breakdown, by Type.
- 12.2.10.3.2 Canada: Organoids Market Breakdown, by Application.
- 12.2.10.3.3 Canada: Organoids Market Breakdown, by Source.
- 12.2.10.3.4 Canada: Organoids Market Breakdown, by Offering.
- 12.2.10.3.5 Canada: Organoids Market Breakdown, by Instruments.
- 12.2.10.3.6 Canada: Organoids Market Breakdown, by Consumables.
- 12.2.10.3.7 Canada: Organoids Market Breakdown, by Method.
- 12.2.10.4 Mexico: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.2.10.4.1 Mexico: Organoids Market Breakdown, by Type.
- 12.2.10.4.2 Mexico: Organoids Market Breakdown, by Application.
- 12.2.10.4.3 Mexico: Organoids Market Breakdown, by Source.
- 12.2.10.4.4 Mexico: Organoids Market Breakdown, by Offering.
- 12.2.10.4.5 Mexico: Organoids Market Breakdown, by Instruments.
- 12.2.10.4.6 Mexico: Organoids Market Breakdown, by Consumables.
- 12.2.10.4.7 Mexico: Organoids Market Breakdown, by Method.
- 12.3 Europe.
- 12.3.1 Europe Organoids Market Overview.
- 12.3.2 Europe: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.3.3 Europe: Organoids Market Breakdown, by Type.
- 12.3.3.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Type.
- 12.3.4 Europe: Organoids Market Breakdown, by Application.
- 12.3.4.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Application.
- 12.3.5 Europe: Organoids Market Breakdown, by Source.
- 12.3.5.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Source.
- 12.3.6 Europe: Organoids Market Breakdown, by Offering.
- 12.3.6.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Offering.
- 12.3.7 Europe: Organoids Market Breakdown, by Instruments.
- 12.3.7.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Instruments.
- 12.3.8 Europe: Organoids Market Breakdown, by Consumables.
- 12.3.8.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Consumables.
- 12.3.9 Europe: Organoids Market Breakdown, by Method.
- 12.3.9.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Method.
- 12.3.10 Europe: Organoids Market - Revenue and Forecast Analysis - by Country.
- 12.3.10.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Country.
- 12.3.10.2 Germany: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.3.10.2.1 Germany: Organoids Market Breakdown, by Type.
- 12.3.10.2.2 Germany: Organoids Market Breakdown, by Application.
- 12.3.10.2.3 Germany: Organoids Market Breakdown, by Source.
- 12.3.10.2.4 Germany: Organoids Market Breakdown, by Offering.
- 12.3.10.2.5 Germany: Organoids Market Breakdown, by Instruments.
- 12.3.10.2.6 Germany: Organoids Market Breakdown, by Consumables.
- 12.3.10.2.7 Germany: Organoids Market Breakdown, by Method.
- 12.3.10.3 France: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.3.10.3.1 France: Organoids Market Breakdown, by Type.
- 12.3.10.3.2 France: Organoids Market Breakdown, by Application.
- 12.3.10.3.3 France: Organoids Market Breakdown, by Source.
- 12.3.10.3.4 France: Organoids Market Breakdown, by Offering.
- 12.3.10.3.5 France: Organoids Market Breakdown, by Instruments.
- 12.3.10.3.6 France: Organoids Market Breakdown, by Consumables.
- 12.3.10.3.7 France: Organoids Market Breakdown, by Method.
- 12.3.10.4 United Kingdom: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.3.10.4.1 United Kingdom: Organoids Market Breakdown, by Type.
- 12.3.10.4.2 United Kingdom: Organoids Market Breakdown, by Application.
- 12.3.10.4.3 United Kingdom: Organoids Market Breakdown, by Source.
- 12.3.10.4.4 United Kingdom: Organoids Market Breakdown, by Offering.
- 12.3.10.4.5 United Kingdom: Organoids Market Breakdown, by Instruments.
- 12.3.10.4.6 United Kingdom: Organoids Market Breakdown, by Consumables.
- 12.3.10.4.7 United Kingdom: Organoids Market Breakdown, by Method.
- 12.3.10.5 Italy: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.3.10.5.1 Italy: Organoids Market Breakdown, by Type.
- 12.3.10.5.2 Italy: Organoids Market Breakdown, by Application.
- 12.3.10.5.3 Italy: Organoids Market Breakdown, by Source.
- 12.3.10.5.4 Italy: Organoids Market Breakdown, by Offering.
- 12.3.10.5.5 Italy: Organoids Market Breakdown, by Instruments.
- 12.3.10.5.6 Italy: Organoids Market Breakdown, by Consumables.
- 12.3.10.5.7 Italy: Organoids Market Breakdown, by Method.
- 12.3.10.6 Spain: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.3.10.6.1 Spain: Organoids Market Breakdown, by Type.
- 12.3.10.6.2 Spain: Organoids Market Breakdown, by Application.
- 12.3.10.6.3 Spain: Organoids Market Breakdown, by Source.
- 12.3.10.6.4 Spain: Organoids Market Breakdown, by Offering.
- 12.3.10.6.5 Spain: Organoids Market Breakdown, by Instruments.
- 12.3.10.6.6 Spain: Organoids Market Breakdown, by Consumables.
- 12.3.10.6.7 Spain: Organoids Market Breakdown, by Method.
- 12.3.10.7 Rest of Europe: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.3.10.7.1 Rest of Europe: Organoids Market Breakdown, by Type.
- 12.3.10.7.2 Rest of Europe: Organoids Market Breakdown, by Application.
- 12.3.10.7.3 Rest of Europe: Organoids Market Breakdown, by Source.
- 12.3.10.7.4 Rest of Europe: Organoids Market Breakdown, by Offering.
- 12.3.10.7.5 Rest of Europe: Organoids Market Breakdown, by Instruments.
- 12.3.10.7.6 Rest of Europe: Organoids Market Breakdown, by Consumables.
- 12.3.10.7.7 Rest of Europe: Organoids Market Breakdown, by Method.
- 12.4 Asia Pacific.
- 12.4.1 Asia Pacific Organoids Market Overview.
- 12.4.2 Asia Pacific: Organoids Market - Revenue and Forecast to 2031 (US$ Million) 13
- 12.4.3 Asia Pacific: Organoids Market Breakdown, by Type.
- 12.4.3.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Type.
- 12.4.4 Asia Pacific: Organoids Market Breakdown, by Application.
- 12.4.4.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Application.
- 12.4.5 Asia Pacific: Organoids Market Breakdown, by Source.
- 12.4.5.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Source.
- 12.4.6 Asia Pacific: Organoids Market Breakdown, by Offering.
- 12.4.6.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Offering.
- 12.4.7 Asia Pacific: Organoids Market Breakdown, by Instruments.
- 12.4.7.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Instruments.
- 12.4.8 Asia Pacific: Organoids Market Breakdown, by Consumables.
- 12.4.8.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Consumables.
- 12.4.9 Asia Pacific: Organoids Market Breakdown, by Method.
- 12.4.9.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Method.
- 12.4.10 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Country.
- 12.4.10.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Country.
- 12.4.10.2 Japan: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.4.10.2.1 Japan: Organoids Market Breakdown, by Type.
- 12.4.10.2.2 Japan: Organoids Market Breakdown, by Application.
- 12.4.10.2.3 Japan: Organoids Market Breakdown, by Source.
- 12.4.10.2.4 Japan: Organoids Market Breakdown, by Offering
- 12.4.10.2.5 Japan: Organoids Market Breakdown, by Instruments.
- 12.4.10.2.6 Japan: Organoids Market Breakdown, by Consumables.
- 12.4.10.2.7 Japan: Organoids Market Breakdown, by Method.
- 12.4.10.3 China: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.4.10.3.1 China: Organoids Market Breakdown, by Type.
- 12.4.10.3.2 China: Organoids Market Breakdown, by Application.
- 12.4.10.3.3 China: Organoids Market Breakdown, by Source.
- 12.4.10.3.4 China: Organoids Market Breakdown, by Offering.
- 12.4.10.3.5 China: Organoids Market Breakdown, by Instruments.
- 12.4.10.3.6 China: Organoids Market Breakdown, by Consumables.
- 12.4.10.3.7 China: Organoids Market Breakdown, by Method.
- 12.4.10.4 India: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.4.10.4.1 India: Organoids Market Breakdown, by Type.
- 12.4.10.4.2 India: Organoids Market Breakdown, by Application
- 12.4.10.4.3 India: Organoids Market Breakdown, by Source.
- 12.4.10.4.4 India: Organoids Market Breakdown, by Offering
- 12.4.10.4.5 India: Organoids Market Breakdown, by Instruments.
- 12.4.10.4.6 India: Organoids Market Breakdown, by Consumables.
- 12.4.10.4.7 India: Organoids Market Breakdown, by Method.
- 12.4.10.5 South Korea: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.4.10.5.1 South Korea: Organoids Market Breakdown, by Type.
- 12.4.10.5.2 South Korea: Organoids Market Breakdown, by Application.
- 12.4.10.5.3 South Korea: Organoids Market Breakdown, by Source.
- 12.4.10.5.4 South Korea: Organoids Market Breakdown, by Offering.
- 12.4.10.5.5 South Korea: Organoids Market Breakdown, by Instruments.
- 12.4.10.5.6 South Korea: Organoids Market Breakdown, by Consumables.
- 12.4.10.5.7 South Korea: Organoids Market Breakdown, by Method.
- 12.4.10.6 Australia: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.4.10.6.1 Australia: Organoids Market Breakdown, by Type.
- 12.4.10.6.2 Australia: Organoids Market Breakdown, by Application.
- 12.4.10.6.3 Australia: Organoids Market Breakdown, by Source.
- 12.4.10.6.4 Australia: Organoids Market Breakdown, by Offering.
- 12.4.10.6.5 Australia: Organoids Market Breakdown, by Instruments.
- 12.4.10.6.6 Australia: Organoids Market Breakdown, by Consumables.
- 12.4.10.6.7 Australia: Organoids Market Breakdown, by Method.
- 12.4.10.7 Singapore: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.4.10.7.1 Singapore: Organoids Market Breakdown, by Type.
- 12.4.10.7.2 Singapore: Organoids Market Breakdown, by Application.
- 12.4.10.7.3 Singapore: Organoids Market Breakdown, by Source.
- 12.4.10.7.4 Singapore: Organoids Market Breakdown, by Offering.
- 12.4.10.7.5 Singapore: Organoids Market Breakdown, by Instruments.
- 12.4.10.7.6 Singapore: Organoids Market Breakdown, by Consumables.
- 12.4.10.7.7 Singapore: Organoids Market Breakdown, by Method.
- 12.4.10.8 Thailand: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.4.10.8.1 Thailand: Organoids Market Breakdown, by Type.
- 12.4.10.8.2 Thailand: Organoids Market Breakdown, by Application.
- 12.4.10.8.3 Thailand: Organoids Market Breakdown, by Source.
- 12.4.10.8.4 Thailand: Organoids Market Breakdown, by Offering.
- 12.4.10.8.5 Thailand: Organoids Market Breakdown, by Instruments.
- 12.4.10.8.6 Thailand: Organoids Market Breakdown, by Consumables.
- 12.4.10.8.7 Thailand: Organoids Market Breakdown, by Method.
- 12.4.10.9 Malaysia: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.4.10.9.1 Malaysia: Organoids Market Breakdown, by Type.
- 12.4.10.9.2 Malaysia: Organoids Market Breakdown, by Application.
- 12.4.10.9.3 Malaysia: Organoids Market Breakdown, by Source.
- 12.4.10.9.4 Malaysia: Organoids Market Breakdown, by Offering.
- 12.4.10.9.5 Malaysia: Organoids Market Breakdown, by Instruments.
- 12.4.10.9.6 Malaysia: Organoids Market Breakdown, by Consumables.
- 12.4.10.9.7 Malaysia: Organoids Market Breakdown, by Method.
- 12.4.10.10 Vietnam: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.4.10.10.1 Vietnam: Organoids Market Breakdown, by Type.
- 12.4.10.10.2 Vietnam: Organoids Market Breakdown, by Application.
- 12.4.10.10.3 Vietnam: Organoids Market Breakdown, by Source.
- 12.4.10.10.4 Vietnam: Organoids Market Breakdown, by Offering.
- 12.4.10.10.5 Vietnam: Organoids Market Breakdown, by Instruments.
- 12.4.10.10.6 Vietnam: Organoids Market Breakdown, by Consumables.
- 12.4.10.10.7 Vietnam: Organoids Market Breakdown, by Method.
- 12.4.10.11 Indonesia: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.4.10.11.1 Indonesia: Organoids Market Breakdown, by Type.
- 12.4.10.11.2 Indonesia: Organoids Market Breakdown, by Application.
- 12.4.10.11.3 Indonesia: Organoids Market Breakdown, by Source.
- 12.4.10.11.4 Indonesia: Organoids Market Breakdown, by Offering.
- 12.4.10.11.5 Indonesia: Organoids Market Breakdown, by Instruments.
- 12.4.10.11.6 Indonesia: Organoids Market Breakdown, by Consumables.
- 12.4.10.11.7 Indonesia: Organoids Market Breakdown, by Method.
- 12.4.10.12 Philippines: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.4.10.12.1 Philippines: Organoids Market Breakdown, by Type.
- 12.4.10.12.2 Philippines: Organoids Market Breakdown, by Application.
- 12.4.10.12.3 Philippines: Organoids Market Breakdown, by Source.
- 12.4.10.12.4 Philippines: Organoids Market Breakdown, by Offering.
- 12.4.10.12.5 Philippines: Organoids Market Breakdown, by Instruments.
- 12.4.10.12.6 Philippines: Organoids Market Breakdown, by Consumables.
- 12.4.10.12.7 Philippines: Organoids Market Breakdown, by Method.
- 12.4.10.13 Rest of APAC: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.4.10.13.1 Rest of APAC: Organoids Market Breakdown, by Type.
- 12.4.10.13.2 Rest of APAC: Organoids Market Breakdown, by Application.
- 12.4.10.13.3 Rest of APAC: Organoids Market Breakdown, by Source.
- 12.4.10.13.4 Rest of APAC: Organoids Market Breakdown, by Offering.
- 12.4.10.13.5 Rest of APAC: Organoids Market Breakdown, by Instruments.
- 12.4.10.13.6 Rest of APAC: Organoids Market Breakdown, by Consumables.
- 12.4.10.13.7 Rest of APAC: Organoids Market Breakdown, by Method.
- 12.5 Middle East and Africa.
- 12.5.1 Middle East and Africa Organoids Market Overview.
- 12.5.2 Middle East and Africa: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.5.3 Middle East and Africa: Organoids Market Breakdown, by Type.
- 12.5.3.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Type.
- 12.5.4 Middle East and Africa: Organoids Market Breakdown, by Application.
- 12.5.4.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Application.
- 12.5.5 Middle East and Africa: Organoids Market Breakdown, by Source.
- 12.5.5.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Source.
- 12.5.6 Middle East and Africa: Organoids Market Breakdown, by Offering.
- 12.5.6.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Offering.
- 12.5.7 Middle East and Africa: Organoids Market Breakdown, by Instruments.
- 12.5.7.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Instruments.
- 12.5.8 Middle East and Africa: Organoids Market Breakdown, by Consumables.
- 12.5.8.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Consumables.
- 12.5.9 Middle East and Africa: Organoids Market Breakdown, by Method.
- 12.5.9.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Method.
- 12.5.10 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Country.
- 12.5.10.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Country.
- 12.5.10.2 Saudi Arabia: Organoids Market - Revenue and Forecast to 2031 (US$ Million
- 12.5.10.2.1 Saudi Arabia: Organoids Market Breakdown, by Type.
- 12.5.10.2.2 Saudi Arabia: Organoids Market Breakdown, by Application.
- 12.5.10.2.3 Saudi Arabia: Organoids Market Breakdown, by Source.
- 12.5.10.2.4 Saudi Arabia: Organoids Market Breakdown, by Offering.
- 12.5.10.2.5 Saudi Arabia: Organoids Market Breakdown, by Instruments.
- 12.5.10.2.6 Saudi Arabia: Organoids Market Breakdown, by Consumables.
- 12.5.10.2.7 Saudi Arabia: Organoids Market Breakdown, by Method.
- 12.5.10.3 South Africa: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.5.10.3.1 South Africa: Organoids Market Breakdown, by Type.
- 12.5.10.3.2 South Africa: Organoids Market Breakdown, by Application.
- 12.5.10.3.3 South Africa: Organoids Market Breakdown, by Source.
- 12.5.10.3.4 South Africa: Organoids Market Breakdown, by Offering.
- 12.5.10.3.5 South Africa: Organoids Market Breakdown, by Instruments.
- 12.5.10.3.6 South Africa: Organoids Market Breakdown, by Consumables.
- 12.5.10.3.7 South Africa: Organoids Market Breakdown, by Method.
- 12.5.10.4 United Arab Emirates: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.5.10.4.1 United Arab Emirates: Organoids Market Breakdown, by Type.
- 12.5.10.4.2 United Arab Emirates: Organoids Market Breakdown, by Application.
- 12.5.10.4.3 United Arab Emirates: Organoids Market Breakdown, by Source.
- 12.5.10.4.4 United Arab Emirates: Organoids Market Breakdown, by Offering.
- 12.5.10.4.5 United Arab Emirates: Organoids Market Breakdown, by Instruments.
- 12.5.10.4.6 United Arab Emirates: Organoids Market Breakdown, by Consumables.
- 12.5.10.4.7 United Arab Emirates: Organoids Market Breakdown, by Method.
- 12.5.10.5 Rest of Middle East and Africa: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.5.10.5.1 Rest of Middle East and Africa: Organoids Market Breakdown, by Type.
- 12.5.10.5.2 Rest of Middle East and Africa: Organoids Market Breakdown, by Application.
- 12.5.10.5.3 Rest of Middle East and Africa: Organoids Market Breakdown, by Source.
- 12.5.10.5.4 Rest of Middle East and Africa: Organoids Market Breakdown, by Offering.
- 12.5.10.5.5 Rest of Middle East and Africa: Organoids Market Breakdown, by Instruments.
- 12.5.10.5.6 Rest of Middle East and Africa: Organoids Market Breakdown, by Consumables.
- 12.5.10.5.7 Rest of Middle East and Africa: Organoids Market Breakdown, by Method.
- 12.6 South and Central America.
- 12.6.1 South and Central America Organoids Market Overview.
- 12.6.2 South and Central America: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.6.3 South and Central America: Organoids Market Breakdown, by Type.
- 12.6.3.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Type.
- 12.6.4 South and Central America: Organoids Market Breakdown, by Application.
- 12.6.4.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Application.
- 12.6.5 South and Central America: Organoids Market Breakdown, by Source.
- 12.6.5.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Source.
- 12.6.6 South and Central America: Organoids Market Breakdown, by Offering.
- 12.6.6.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Offering.
- 12.6.7 South and Central America: Organoids Market Breakdown, by Instruments.
- 12.6.7.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Instruments.
- 12.6.8 South and Central America: Organoids Market Breakdown, by Consumables.
- 12.6.8.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Consumables.
- 12.6.9 South and Central America: Organoids Market Breakdown, by Method.
- 12.6.9.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Method.
- 12.6.10 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Country.
- 12.6.10.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Country.
- 12.6.10.2 Brazil: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.6.10.2.1 Brazil: Organoids Market Breakdown, by Type.
- 12.6.10.2.2 Brazil: Organoids Market Breakdown, by Application.
- 12.6.10.2.3 Brazil: Organoids Market Breakdown, by Source.
- 12.6.10.2.4 Brazil: Organoids Market Breakdown, by Offering.
- 12.6.10.2.5 Brazil: Organoids Market Breakdown, by Instruments.
- 12.6.10.2.6 Brazil: Organoids Market Breakdown, by Consumables.
- 12.6.10.2.7 Brazil: Organoids Market Breakdown, by Method.
- 12.6.10.3 Argentina: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.6.10.3.1 Argentina: Organoids Market Breakdown, by Type.
- 12.6.10.3.2 Argentina: Organoids Market Breakdown, by Application.
- 12.6.10.3.3 Argentina: Organoids Market Breakdown, by Source.
- 12.6.10.3.4 Argentina: Organoids Market Breakdown, by Offering.
- 12.6.10.3.5 Argentina: Organoids Market Breakdown, by Instruments.
- 12.6.10.3.6 Argentina: Organoids Market Breakdown, by Consumables.
- 12.6.10.3.7 Argentina: Organoids Market Breakdown, by Method.
- 12.6.10.4 Rest of South and Central America: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
- 12.6.10.4.1 Rest of South and Central America: Organoids Market Breakdown, by Type.
- 12.6.10.4.2 Rest of South and Central America: Organoids Market Breakdown, by Application.
- 12.6.10.4.3 Rest of South and Central America: Organoids Market Breakdown, by Source.
- 12.6.10.4.4 Rest of South and Central America: Organoids Market Breakdown, by Offering.
- 12.6.10.4.5 Rest of South and Central America: Organoids Market Breakdown, by Instruments.
- 12.6.10.4.6 Rest of South and Central America: Organoids Market Breakdown, by Consumables.
- 12.6.10.4.7 Rest of South and Central America: Organoids Market Breakdown, by Method.
13. Industry Landscape
- 13.1 Overview.
- 13.2 Growth Strategies in Organoids Market
- 13.3 Organic Growth Strategies.
- 13.3.1 Overview.
- 13.4 Inorganic Growth Strategies.
- 13.4.1 Overview.
14. Company Profiles
- 14.1 STEMCELL Technologies Inc.
- 14.1.1 Key Facts.
- 14.1.2 Business Description.
- 14.1.3 Products and Services.
- 14.1.4 Financial Overview.
- 14.1.5 SWOT Analysis.
- 14.1.6 Key Developments.
- 14.2 Molecular Devices, LLC.
- 14.2.1 Key Facts.
- 14.2.2 Business Description.
- 14.2.3 Products and Services.
- 14.2.4 Financial Overview.
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments.
- 14.3 Hubrecht Organoid Technology.
- 14.3.1 Key Facts.
- 14.3.2 Business Description.
- 14.3.3 Products and Services.
- 14.3.4 Financial Overview.
- 14.3.5 SWOT Analysis.
- 14.3.6 Key Developments.
- 14.4 Definigen.
- 14.4.1 Key Facts.
- 14.4.2 Business Description.
- 14.4.3 Products and Services.
- 14.4.4 Financial Overview.
- 14.4.5 SWOT Analysis.
- 14.4.6 Key Developments.
- 14.5 Organoid Therapeutics.
- 14.5.1 Key Facts.
- 14.5.2 Business Description.
- 14.5.3 Products and Services.
- 14.5.4 Financial Overview.
- 14.5.5 SWOT Analysis.
- 14.5.6 Key Developments.
- 14.6 Thermo Fisher Scientific Inc.
- 14.6.1 Key Facts.
- 14.6.2 Business Description.
- 14.6.3 Products and Services.
- 14.6.4 Financial Overview.
- 14.6.5 SWOT Analysis.
- 14.6.6 Key Developments.
- 14.7 Corning Inc.
- 14.7.1 Key Facts.
- 14.7.2 Business Description.
- 14.7.3 Products and Services.
- 14.7.4 Financial Overview.
- 14.7.5 SWOT Analysis.
- 14.7.6 Key Developments.
- 14.8 Merck KGaA.
- 14.8.1 Key Facts.
- 14.8.2 Business Description.
- 14.8.3 Products and Services.
- 14.8.4 Financial Overview.
- 14.8.5 SWOT Analysis.
- 14.8.6 Key Developments.
- 14.9 InSphero.
- 14.9.1 Key Facts.
- 14.9.2 Business Description.
- 14.9.3 Products and Services.
- 14.9.4 Financial Overview.
- 14.9.5 SWOT Analysis.
- 14.9.6 Key Developments.
- 14.10 ACRO Biosystems.
- 14.10.1 Key Facts.
- 14.10.2 Business Description.
- 14.10.3 Products and Services.
- 14.10.4 Financial Overview.
- 14.10.5 SWOT Analysis.
- 14.10.6 Key Developments.
- 14.11 Bio-Techne Corp.
- 14.11.1 Key Facts.
- 14.11.2 Business Description.
- 14.11.3 Products and Services.
- 14.11.4 Financial Overview.
- 14.11.5 SWOT Analysis.
- 14.11.6 Key Developments.
- 14.12 SUN bioscience SA.
- 14.12.1 Key Facts.
- 14.12.2 Business Description.
- 14.12.3 Products and Services.
- 14.12.4 Financial Overview.
- 14.12.5 SWOT Analysis.
- 14.12.6 Key Developments.
- 14.13 ORGANOID SCIENCES Co., Ltd.
- 14.13.1 Key Facts.
- 14.13.2 Business Description.
- 14.13.3 Products and Services.
- 14.13.4 Financial Overview.
- 14.13.5 SWOT Analysis.
- 14.13.6 Key Developments.
- 14.14 Crown Bioscience Inc.
- 14.14.1 Key Facts.
- 14.14.2 Business Description.
- 14.14.3 Products and Services.
- 14.14.4 Financial Overview.
- 14.14.5 SWOT Analysis.
- 14.14.6 Key Developments.
- 14.15 Sartorius AG.
- 14.15.1 Key Facts.
- 14.15.2 Business Description.
- 14.15.3 Products and Services.
- 14.15.4 Financial Overview.
- 14.15.5 SWOT Analysis.
- 14.15.6 Key Developments.
- 14.16 3D Biotek LLC.
- 14.16.1 Key Facts.
- 14.16.2 Business Description.
- 14.16.3 Products and Services.
- 14.16.4 Financial Overview.
- 14.16.5 SWOT Analysis.
- 14.16.6 Key Developments.
- 14.17 Prellis Biologics Inc.
- 14.17.1 Key Facts.
- 14.17.2 Business Description.
- 14.17.3 Products and Services.
- 14.17.4 Financial Overview.
- 14.17.5 SWOT Analysis.
- 14.17.6 Key Developments.
- 14.18 3Dnamics Inc.
- 14.18.1 Key Facts.
- 14.18.2 Business Description.
- 14.18.3 Products and Services.
- 14.18.4 Financial Overview.
- 14.18.5 SWOT Analysis.
- 14.18.6 Key Developments.
- 14.19 Cellesce Ltd.
- 14.19.1 Key Facts.
- 14.19.2 Business Description.
- 14.19.3 Products and Services.
- 14.19.4 Financial Overview.
- 14.19.5 SWOT Analysis.
- 14.19.6 Key Developments.
15. Appendix
- 15.1 About The Insight Partners.
